https://pipelinereview.com/index-pharmaceuticals-discontinues-cobitolimod-phase-iii-program/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Flyme%2Fstats%2Findex.html%5C%5C%22